rethinkTHC Search
Menu
Study breakdown

Cannabis extract relieved neuropathic pain in rats comparably to gabapentin

Animal StudyLow evidence
The takeaway

Two cannabis extracts showed pain-relieving effects comparable to gabapentin in a rat neuropathic pain model, with complex effects on CB1 and CB2 receptor expression that varied by brain region and dose.

Neuropathic pain researchers, pain medicine specialists, patients exploring cannabis for nerve pain

Pain relief comparable to gabapentin

What the researchers found

Cannabis extracts demonstrated antinociceptive effects comparable to gabapentin in vincristine-induced neuropathic pain. CB1R protein expression increased in hippocampus with both extracts but decreased in cortex. CB2R expression increased in hippocampus and cortex with extract B. Receptor changes alone did not fully explain behavioral effects.

Why it matters

Neuropathic pain is notoriously difficult to treat, and gabapentin is a first-line therapy with significant side effects. Finding that cannabis extracts match gabapentin's pain relief with different side effect profiles could offer patients alternatives.

The numbers in context

130 rats. Gabapentin 60 mg/kg reference dose. Extract D doses: 10, 20, 40 mg/kg. Extract B doses: 5, 7.5, 10, 20 mg/kg. Pain relief comparable to gabapentin.

How the study worked

130 male Wistar rats divided into groups receiving vincristine (to induce neuropathic pain), gabapentin, or two cannabis extracts (D and B) at various doses. CB1R and CB2R mRNA and protein expression measured in cortex, hippocampus, and lymphocytes. Behavioral tests: Tail-Flick and von Frey.

What this study cannot tell us

Rat model with vincristine-induced neuropathy may not replicate human neuropathic pain. Only male rats studied. Specific cannabinoid composition of extracts not fully characterized. Cannot translate doses directly to humans.

How to read the evidence

Controlled animal study with behavioral and molecular endpoints, but limited human translatability.

When this study was published

2024 rat study of cannabis extracts for vincristine-induced neuropathic pain

The bigger picture

The finding that cannabinoid receptor changes did not fully explain pain relief suggests cannabis extracts work through additional pathways beyond the endocannabinoid system, which could include anti-inflammatory, GABAergic, or serotonergic mechanisms.

Questions still open

  • Which additional signaling pathways contribute to cannabis extract pain relief? Would similar efficacy be seen in other neuropathic pain models or in human trials?

Common questions

Is cannabis as effective as gabapentin for nerve pain?
In this rat study, cannabis extracts showed comparable pain relief to gabapentin. However, animal results do not directly translate to humans, and clinical trials in people are needed to confirm this comparison.
How do cannabis extracts relieve pain?
The study found changes in cannabinoid receptor expression but noted these did not fully explain the pain relief, suggesting additional signaling pathways beyond the endocannabinoid system contribute to the effect.

Read the original research

Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.

Biomolecules, 14(9)

Citation

Bartkowiak-Wieczorek, Joanna; Bienert, Agnieszka; Czora-Poczwardowska, Kamila; Kujawski, Radosław; Szulc, Michał; Mikołajczak, Przemysław; Wizner, Anna-Maria; Jamka, Małgorzata; Hołysz, Marcin; Wielgus, Karolina; Słomski, Ryszard; Mądry, Edyta. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.. Biomolecules, 14(9). https://doi.org/10.3390/biom14091065

Explore the wider topic